Algorhythm Holdings Reports $1.744M Net Sales and $351K Gross Loss for Quarter Ending September 30, 2025

Algorhythm Holdings, Inc. reported significant financial changes in its latest 10-Q filing for the quarter ending September 30, 2025. The company generated net sales of $1.744 million for the three months ended September 30, 2025, a substantial increase from $127,000 during the same period in 2024. This growth is attributed primarily to the acquisition of SMCB, which was completed on May 2, 2025. However, the company also reported a gross loss of $351,000 for the quarter, compared to a loss of $32,000 in the prior year, reflecting increased costs associated with the new business operations.

In terms of overall financial health, Algorhythm's total assets decreased to $10.845 million as of September 30, 2025, down from $18.302 million at the end of 2024. The decline in assets is largely due to the sale of its Singing Machine business, which was completed on August 1, 2025, for $500,000. The company’s liabilities also saw a significant reduction, totaling $10.745 million compared to $28.823 million at the end of the previous fiscal year, primarily due to the elimination of the warrant liability following the reclassification of certain warrants to equity.

Operationally, Algorhythm has shifted its focus entirely to its SemiCab business following the divestiture of Singing Machine. The company is now positioned as a single reportable segment, concentrating on AI-enabled logistics and distribution services. The acquisition of SMCB has expanded its operational footprint, particularly in India, where it aims to leverage its technology to enhance transportation efficiency. The company reported that 56% of its accounts receivable were concentrated with two customers in India, highlighting both a potential risk and opportunity for growth.

Looking ahead, Algorhythm anticipates a substantial increase in net sales from its SemiCab business over the next 12 months, driven by a growing customer base. However, the company also faces challenges, including a projected increase in operating expenses as it invests in marketing and development. The company’s cash balance stood at $2.839 million as of September 30, 2025, which management indicated may not be sufficient to fund operations for the next year without additional capital. Algorhythm plans to seek further financing through equity or debt to support its growth strategy, although it acknowledges the uncertainty surrounding the availability of such capital.